Transforming growth factor-β expression in prostate neoplasia

Analytical and Quantitative Cytology and Histology

Volumn 22, Issue 1, 2000, Pages 1-10

  Cardillo, Maria Rosaria ^a   Petrangeli, Elisa ^b   Perracchio, Letizia ^a   Salvatori, Luisa ^b   Ravenna, Linda ^b   Di Silverio, Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

Author keywords

Benign; Prostate neoplasms; Prostatic hypertrophy; Prostatic intraepithelial neoplasia; Transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; AUTOCRINE EFFECT; CANCER GRADING; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; STROMA;

ACTIVIN RECEPTORS, TYPE I; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033982228     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Nemeth JA, Sensobar JA, White RR, Zelner DJ, Kim IJ, Lee C: Prostatic ductal system in rats: Tissue-specific expression and regional variation in stromal distribution of transforming growth factor-β1. Prostate 1997;33:64-71
2. Massague J: The transforming growth factor-beta family. Annu Rev Cell Biol 1990;6:597-641
3. Chambaz EM, Souchelnitsky S, Pellerin S, Defaye G, Cochet C, Feige J: Transforming growth factor βs: A multifunctional cytokine family. Horm Res 1996;45:222-226
4. Roberts AB, Sporn MB: The transforming growth factor βs. In Peptide Growth Factors and Their Receptors. Part I. Edited by MB Sporn, AB Roberts. Berlin, Springer-Verlag, 1990, pp 419-472
5. Knabbe C, Klein H, Zugmaier G, Voigt KD: Hormonal regulation of transforming growth factor β-2 expression in human prostate cancer. J Steroid Biochem 1993;47:137-142
6. Mori H, Maki M, Oiski K, Jave M, Igarashi K, Yoshida O, Hatanaka M: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia. Prostate 1990;16: 71-80
7. Merz VW, Arnold AM, Studer UE: Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer. World J Urol 1994;12:96-98
8. Troung LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC: Association of transforming growth factor β1 with prostate cancer: An immunohistochemical study. Hum Pathol 1993;24:4-9
9. Story MT, Hopp KA, Molter M: Expression of transforming growth factor beta 1 (TGFβ1), β2 and β3 by cultured human prostate cells. J Cell Physiol 1996;169:97-107
10. Lin HY, Wang X, Ng-Eaton E, Weinberg RA, Iodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992;68: 775-785
11. Ebner R, Chen R, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R: Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 1993;260:1344-1348
12. Franzen P, tenDijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K: Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 1993;75:681-692
13. Wrana JL, Attisano L, Weiser R, Ventura F, Massague J: Mechanism of activation of the TGF-β-receptor. Nature 1994;370:341-347
14. Hata A, Shi Y, Massague J: TGF-β signaling and cancer: Structural and functional consequences of mutations in Smads. Mol Med Today 1998;4:257-262
15. Massague J: TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791
16. Franzen P, Ten Djike P, Ichjio H, Yamashita H, Schulz P, Heldin C, Miyazomo K: Cloning of a TGF-β type I receptor that forms a heteroduplex with the TGF-β type II receptor. Cell 1994;67:785-795
17. Guo Y, Kyprianou N: Overexpression of transforming growth factor (TGF) β1 type II receptor restores TGF-β1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ 1998;9:185-193
18. Guo Y, Jacobs SC, Kyprianou N: Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer. Int J Cancer 1997;71:573-579
19. Williams RH, Stapleton AMF, Yang G, Truong LD, Rogers E, Timme TL, Wheeler TM, Scardino PT, Thompson TC: Reduced levels of transforming growth factor β receptor type II in human prostate cancer: An immunohistochemical study. Clin Cancer Res 1996;2:635-640
20. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozowski K, Lee C: Loss of expression of transforming growth factor β type I and II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 1996;2:1255-1261
21. Gerdes MJ, Larsen M, McBridge L, Dang TD, Lu B, Rowley DR: Localization of transforming growth factor β1 and type II receptor in developing normal human prostate and carcinoma tissue. J Histochem Cytochem 1998;46:379-388
22. Barrack ER: TGFβ in prostate cancer: A growth inhibitor that can enhance tumorigenicity. Prostate 1997;31:61-70
23. Sun L, Wu G, Wilson JK, Zborowska E, Yang J, Rajakarunanyake J, Wang J, Gentry LE, Wang X-F, Brattain MG: Expression of transforming growth factor-β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 1994;269:26449-26455
24. Kadin ME, Cavill-col MN, Gertz R, Massagué J, Cheifez S, George D: Loss of receptors for transforming growth factor-β in human T-cell malignancies. Proc Natl Acad Sci USA 1994;91:6002-6006
25. Markowitz S, Wang J, Myeroff L, Parson R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Volgelstein B, Britain M, Willson JKV: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338
26. Garrigue-Antar L, Munoz-Antonia SJ, Gesmonde J, Velucci VF, Reiss M: Missense mutations of transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 1995;55:3982-3987
27. Cardillo MR, Petrangeli E, Ravenna L, Salvatori L, Di Silverio F: Transforming growth factor-β expression in human testicular neoplasm. Analyt Quant Cytol Histol 1998;20: 461-469
28. Fafeur V, O'Hara B, Bohlen P: A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-b and other inhibitory cytokines: Evidence for multiple growth inhibitory signal pathway. Mol Biol Cell 1993;4:135-144
29. Arrick BA, Lopez AR, Elfman F, Ebner R, Damsky CH, Derynck R: Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J Cell Biol 1992;118: 715-726
30. Epstein JI: Prostate Biopsy Interpretation. Philadelphia, Lippincott-Raven, 1995
31. Gleason DF: Histologic grading of prostate cancer: A perspective. Hum Pathol 1992;23:273-279
32. TNM Atlas: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. Fourth edition. New York, Springer Verlag, 1997, pp 272-280
33. Sporn MB, Roberts AB, Wekefield LM, Assoian RK: Transforming growth factor-β: Biological function and chemical structure. Science 1986;233:532-534
34. tenDijke P, Hansen P, Iwata KK, Pieler C, Foulkes JG: Identification of a new member of the transforming growth factor type β gene family. Proc Natl Acad Sci USA 1988;85: 4715-4719
35. tenDijke P, Thorikay M, Stewart A, Iwata KK: Recombinant expression and purification of transforming growth factor-β3, a potent growth regulator. Ann NY Acad Sci 1990; 593:36-42
36. Massagué J: Receptors for the TGF-β family. Cell 1992;69: 1067-1070
37. Shain SA, Lin AL, Koger JD: Rat prostate cancer cells contain functional receptors for transforming growth factor-β. Endocrinology 1990;126:818-825
38. Moses HL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990;63:245-247
39. Wilding G: Response of prostate cancer cells to peptide growth factors: Transforming growth factor-beta. Cancer Surv 1991;11:147-163
40. Miniati DN, Chang Y, Shu W-P, Peehl DM, Liu C-S: Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells. Cancer Lett 1996;104:137-144
41. Djonov V, Ball RK, Graf S, Mottaz AE, Arnold AM, Flanders K, Studer UE, Merz VW: Transforming growth factor-β3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma. Prostate 1997;31: 103-109
42. Perry KT, Anthony CT, Steiner MS: Immunohistochemical localization of TGFβ1, TGFβ2 and TGFβ3 in normal and malignant human prostate. Prostate 1997;33:133-140
43. Timme TL, Yang G, Rogers E, Kadmon D, Morganstern JP, Park SH, Thompson TC: Retroviral transduction of transforming growth factor-β1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions. Lab Invest 1996;74:747-760
44. Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC: Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. Endocrinology 1994; 134:1039-1045
45. Eklov S, Funa K, Nordgren H, Olofsson A, Kanazaki T, Miyazono K, Nilsson S: Lack of the latent transforming growth factor β binding protein in malignant, but not benign prostatic tissue. Cancer Res 1993;53:183-190
46. Miyazono K, Olofsson A, Colosetti, Heldin C-H: A role of the latent TGFβ1 binding protein in the assembly and secretion of TGFβ1. EMBO J 1991;10:1091-1101
47. Peehl DM, Leung GK, Wong ST: Keratin expression: A measure of phenotypic modulation of human prostatic epithelial cells by inhibitory factors. Cell Tissue Res 1994;277: 11-18
48. Wang J, Sun LZ, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKW, Brattain MG: Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 1995;270:22044-22049